Linde (LIN) PT Lowered to $549 at RBC Capital

Thu, 15 Oct 2026 09:12:53 -0400

RBC Capital analyst Arun Viswanathan lowered the price target on Linde (NASDAQ: LIN) to $549.00 (from $553.00) while maintaining a Outperform rating.

Bernstein: 'When do I buy Linde (LIN)'

Wed, 14 Oct 2026 08:01:48 -0400

Bernstein SocGen Group analyst James Hooper reiterated an Outperform rating and $563.00 price target on Linde (NASDAQ: LIN).

The analyst commented: "When do I buy Linde? Linde was unsurprisingly the most popular name and most of our meetings included a version of the headline question. The long-term story seemed relatively clear, albeit we had several debates about 1) the long-term space business model: in our view on site take or pay contracts unlocked by second stage rockets becoming fully reusable; and 2) the right approach to Lincare: in our view sell it without undertaking a major fix as the return from

Barclays Starts Linde (LIN) at Overweight

Mon, 12 Oct 2026 16:20:06 -0400

Barclays analyst Aleksey Yefremov initiates coverage on Linde (NASDAQ: LIN) with a Overweight rating and a price target of $577.00.

For an analyst ratings summary and ratings history on Linde click here. For more ratings news on Linde click here.

Shares of Linde closed at $483.73 yesterday.

Form 3 LINDE PLC For: Oct 01 Filed by: Botello Armando

Thu, 08 Oct 2026 18:04:00 -0400

si-local-file:///var/storage/secattach/20261008/27167859.html

BMO Capital: 'Linde (LIN) Speaks to Electronics and Space as Double-Digit Growth Drivers'

Thu, 08 Oct 2026 07:19:40 -0400

BMO Capital analyst John McNulty reiterated an Outperform rating and $546.00 price target on Linde (NASDAQ: LIN).

The analyst commented: "LIN Speaks to Electronics and Space as Double-Digit Growth Drivers; We recently attended LIN's investor event that focused on a deep dive into the long-term opportunities it sees ahead for its Electronics and Space platforms. While management demonstrated excitement around both platforms, the Electronics/Semis opportunity appears more concrete in its longer-term growth trajectory. Space, while appealing from a growth perspective off its modest base, has various questions remaining. All said, we expect LIN to return to its 10% EPS growth algorithm

Form 4 LINDE PLC For: Oct 01 Filed by: Reynolds Paula Rosput

Mon, 05 Oct 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20261005/27150077.html

Form 4 LINDE PLC For: Oct 01 Filed by: GRANT HUGH

Mon, 05 Oct 2026 17:10:00 -0400

si-local-file:///var/storage/secattach/20261005/27149893.html

Linde (LIN) PT Lowered to $574 at UBS

Mon, 05 Oct 2026 09:11:16 -0400

UBS analyst Joshua Spector lowered the price target on Linde (NASDAQ: LIN) to $574.00 (from $612.00) while maintaining a Buy rating.

Bernstein SocGen on Linde (LIN): 'Linde has the capability to ramp up its space business very quickly'

Mon, 05 Oct 2026 08:17:48 -0400

Bernstein SocGen Group analyst James Hooper reiterated an Outperform rating and $563.00 price target on Linde (NASDAQ: LIN).

The analyst commented: "Linde has the capability to ramp up its space business very quickly. The bottleneck is customer launches. Demand is very healthy for launches. Linde brought a customer to the event who noted that militaries / governments / hyperscalers have ample uses for satellites, and launch cadence and full rocket reusability is the bottleneck. The launch estimates shown in the presentation were above our space model (see report The Long View: The Industrial Gas space opportunity - rocket fuel for growth).

Linde Announces Third Quarter 2026 Earnings and Conference Call Schedule

Mon, 05 Oct 2026 06:00:00 -0400

WOKING, England--(BUSINESS WIRE)-- Linde (Nasdaq: LIN) will release its third quarter 2026 financial results by 06:00 EDT/11:00 CET on Thursday, October 29, 2026. The Company will host and webcast its conference call at 09:00 EDT/14:00 CET, which will be available to the public and the media in listen-only mode.

Live conference call	US Toll-Free Dial-In Number: 1 833 461 5787 UK Toll-Free Dial-In Number: 44 808 196 8935 Access code: 806577257

Live conference call	US Toll-Free Dial-In Number: 1 833 461 5787 UK Toll-Free Dial-In Number: 44 808 196 8935 Access code: 806577257
Linde (LIN) PT Lowered to $563 at Bernstein SocGen Group Fri, 11 Sep 2026 09:34:24 -0400 Bernstein SocGen Group analyst James Hooper lowered the price target on Linde (NASDAQ: LIN) to $563.00 (from $564.00) while maintaining a Outperform rating. The analyst commented: "Mapping the future project growth potential; This report is the first in a series examining the earnings contribution from announced projects across global industrial gases. We subsequently updated our models to incorporate projectlevel granularity where possible and the individual contribution to revenue and earnings through 2030. We begin the series with Linde, where we estimate disclosed projects could contribute annual +LSD EPS growth alone. And this doesn’t include space, or further wins in electronics. While KeyBanc Starts Linde (LIN) at Overweight Fri, 11 Sep 2026 05:10:22 -0400 (Updated - September 11, 2026 5:10 AM EDT) KeyBanc analyst Salvator Tiano initiates coverage on Linde (NASDAQ: LIN) with a Overweight rating and a price target of $542.00. The analyst comments "We Initiate Coverage of LIN at OW with a $542 PT. We believe LIN is the highest quality company within our cluster. Although valuation is far from inexpensive, we believe it is well-deserved when considering the combination of the Company’s quality and the emerging tailwinds at its end markets. We also see LIN as one of the main beneficiaries of industrial demand acceleration, as well as skyrocketing investments in electronics/semiconductors; to KeyBanc Starts Linde (LIN) at Overweight Fri, 11 Sep 2026 05:10:22 -0400 (Updated - September 11, 2026 5:10 AM EDT) KeyBanc analyst Salvator Tiano initiates coverage on Linde (NASDAQ: LIN) with a Overweight rating and a price target of $542.00. The analyst comments "We Initiate Coverage of LIN at OW with a $542 PT. We believe LIN is the highest quality company within our cluster. Although valuation is far from inexpensive, we believe it is well-deserved when considering the combination of the Company’s quality and the emerging tailwinds at its end markets. We also see LIN as one of the main beneficiaries of industrial demand acceleration, as well as skyrocketing investments in electronics/semiconductors; to Linde (LIN) call put ratio 1 call to 1.5 puts with a focus on October 420 puts Thu, 10 Sep 2026 05:39:18 -0400 Linde (NASDAQ: LIN) 30-day option implied volatility is at 23; compared to its 52-week range of 17 to 27. Call put ratio 1 call to 1.5 puts with a focus on October 420 puts. UBS Reiterates Buy Rating on Linde (LIN) as Challenges in Helium Are 'Being Managed' Fri, 04 Sep 2026 09:21:19 -0400 UBS analyst Joshua Spector reiterated a Buy rating and $612.00 price target on Linde (NASDAQ: LIN). The analyst commented, "We attended a lunch with LIN CFO & IR. Discussions focused more on strategic topics including LIN's healthcare business (Lincare), helium, the Woodside Blue Ammonia Project and commercial space opportunities. Our overall take is that challenges in Lincare and helium are being managed and should not be a headwind to 2027 earnings. LIN mgmt is aggressively going after costs in Lincare with restructuring. The company expects to show improvement into 3Q, and indicated potential strategic actions if it doesn't meet growth/margin targets Bernstein sees 'an entry point in our top-pick' chemical stock Fri, 21 Aug 2026 00:00:00 -0400 Investing.com-- A recent sell-off has created an opportunity for investors in a chemical stock, with Bernstein arguing that concerns over one of its businesses have been more than reflected in the shares and that the core operations remain well positioned. Bernstein reiterated its Outperform rating on Linde and said the company remains its top pick, despite challenges at its U.S. respiratory homecare business, Lincare. The brokerage kept its $564 price target. Bernstein analysts said Lincare was likely a major factor behind Linde's second-quarter sell-off, when the company's market value fell by about $14 billion. They estimated Lincare could be worth roughly $3 billion Bernstein sees 'an entry point in our top-pick' chemical stock Fri, 21 Aug 2026 00:00:00 -0400 Investing.com-- A recent sell-off has created an opportunity for investors in a chemical stock, with Bernstein arguing that concerns over one of its businesses have been more than reflected in the shares and that the core operations remain well positioned. Bernstein reiterated its Outperform rating on Linde and said the company remains its top pick, despite challenges at its U.S. respiratory homecare business, Lincare. The brokerage kept its $564 price target. Bernstein analysts said Lincare was likely a major factor behind Linde's second-quarter sell-off, when the company's market value fell by about $14 billion. They estimated Lincare could be worth roughly $3 billion Form 4 LINDE PLC For: Aug 18 Filed by: Reynolds Paula Rosput Wed, 19 Aug 2026 15:03:00 -0400 si-local-file:///var/storage/secattach/20260819/26949656.html Form 4 LINDE PLC For: Aug 18 Filed by: Reynolds Paula Rosput Wed, 19 Aug 2026 15:03:00 -0400 si-local-file:///var/storage/secattach/20260819/26949656.html Bernstein SocGen Group Reiterates Outperform Rating on Linde (LIN), 'we see this sell-off as a major overreaction' Wed, 19 Aug 2026 08:14:41 -0400 Bernstein SocGen Group analyst James Hooper reiterated an Outperform rating and $564.00 price target on Linde (NASDAQ: LIN). The analyst commented: "We believe Lincare was one of the main contributing factors driving Linde’s 2Q26 sell-off. And yes, Lincare is challenged, in the short-term by price-cost and longer-term by lack the potential relative to Linde’s industrial gas business. However, we see this sell-off as a major overreaction. Linde’s market cap declined c. $14bn on 2Q26 results day, and we believe Lincare would be worth c. $3bn in a sale. We continue to see an entry point in our top-pick, as the core Citi analyzes positioning in US chemicals stocks Wed, 19 Aug 2026 05:45:18 -0400 Investing.com - Citi released a positioning analysis of US chemicals stocks using data from its Quant team, identifying the most crowded long and short positions within its coverage universe. Ecovyst (NYSE:ECVT), RPM International (NYSE:RPM), and Linde (NASDAQ:LIN) remain the most crowded long positions in Citi's coverage. RPM and LIN swapped positions during the week, with LIN's crowding score declining roughly 1% week-over-week due to weaker sentiment and less favorable historical relative valuation, partially offset by lower short interest. Long crowding across Citi's coverage universe increased approximately 1% week-over-week, rebounding from a roughly 6% decline the previous week. The largest weekly movers included Citi analyzes positioning in US chemicals stocks Wed, 19 Aug 2026 05:45:18 -0400 Investing.com - Citi released a positioning analysis of US chemicals stocks using data from its Quant team, identifying the most crowded long and short positions within its coverage universe. Ecovyst (NYSE:ECVT), RPM International (NYSE:RPM), and Linde (NASDAQ:LIN) remain the most crowded long positions in Citi's coverage. RPM and LIN swapped positions during the week, with LIN's crowding score declining roughly 1% week-over-week due to weaker sentiment and less favorable historical relative valuation, partially offset by lower short interest. Long crowding across Citi's coverage universe increased approximately 1% week-over-week, rebounding from a roughly 6% decline the previous week. The largest weekly movers included Citi analyzes positioning in US chemicals stocks Wed, 19 Aug 2026 05:45:18 -0400 Investing.com - Citi released a positioning analysis of US chemicals stocks using data from its Quant team, identifying the most crowded long and short positions within its coverage universe. Ecovyst (NYSE:ECVT), RPM International (NYSE:RPM), and Linde (NASDAQ:LIN) remain the most crowded long positions in Citi's coverage. RPM and LIN swapped positions during the week, with LIN's crowding score declining roughly 1% week-over-week due to weaker sentiment and less favorable historical relative valuation, partially offset by lower short interest. Long crowding across Citi's coverage universe increased approximately 1% week-over-week, rebounding from a roughly 6% decline the previous week. The largest weekly movers included

StreetInsider.com News Articles

Linde (LIN) PT Lowered to $549 at RBC Capital

Bernstein: 'When do I buy Linde (LIN)'

Barclays Starts Linde (LIN) at Overweight

Form 3 LINDE PLC For: Oct 01 Filed by: Botello Armando

BMO Capital: 'Linde (LIN) Speaks to Electronics and Space as Double-Digit Growth Drivers'

Form 4 LINDE PLC For: Oct 01 Filed by: Reynolds Paula Rosput

Form 4 LINDE PLC For: Oct 01 Filed by: GRANT HUGH

Linde (LIN) PT Lowered to $574 at UBS

Bernstein SocGen on Linde (LIN): 'Linde has the capability to ramp up its space business very quickly'

Linde Announces Third Quarter 2026 Earnings and Conference Call Schedule

Linde (LIN) PT Lowered to $563 at Bernstein SocGen Group

KeyBanc Starts Linde (LIN) at Overweight

KeyBanc Starts Linde (LIN) at Overweight

Linde (LIN) call put ratio 1 call to 1.5 puts with a focus on October 420 puts

UBS Reiterates Buy Rating on Linde (LIN) as Challenges in Helium Are 'Being Managed'

Bernstein sees 'an entry point in our top-pick' chemical stock

Bernstein sees 'an entry point in our top-pick' chemical stock

Form 4 LINDE PLC For: Aug 18 Filed by: Reynolds Paula Rosput

Form 4 LINDE PLC For: Aug 18 Filed by: Reynolds Paula Rosput

Bernstein SocGen Group Reiterates Outperform Rating on Linde (LIN), 'we see this sell-off as a major overreaction'

Citi analyzes positioning in US chemicals stocks

Citi analyzes positioning in US chemicals stocks

Citi analyzes positioning in US chemicals stocks